Contra Fusion Pharmace
13F holders, Q2 2024 (June 30)2holders
$0.00avg. 13F price*
At the end of Q2 2024, 2 institutions reported holding Contra Fusion Pharmace in their 13F filings. The largest holders were Tucker Asset Management LLC ($0) and GAMMA Investing LLC ($0).
- Company
- Contra Fusion Pharmace
- Filed as
- FUSION PHARMACEUTICALS INC CVR from 36118A100 (Q2 2024)
- CUSIP
- 361CVR012
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $0 |
| Exits | 0 | $0 |
Ownership 2 holders
| Tucker Asset Management LLC | 0.00% | New | 3,269 | $0 |
| GAMMA Investing LLC | 0.00% | New | 26 | $0 |
"% of holder's portfolio" is CONTRA FUSION PHARMACE's weight in each manager's 13F, not the share of Contra Fusion Pharmace the manager owns.